Works about ENDOTHELIAL growth factors


Results: 3001
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 121, n. 3, p. 557, doi. 10.1007/s11060-014-1667-z
    By:
    • Taylor, Jennie;
    • Dietrich, Jorg;
    • Gerstner, Elizabeth;
    • Norden, Andrew;
    • Rinne, Mikael;
    • Cahill, Daniel;
    • Stemmer-Rachamimov, Anat;
    • Wen, Patrick;
    • Betensky, Rebecca;
    • Giorgio, Diana;
    • Snodgrass, Kellis;
    • Randall, Alison;
    • Batchelor, Tracy;
    • Chi, Andrew
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Factors Affecting Visual Acuity After Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration: A Multicenter Study in Japan.

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 20, p. 6244, doi. 10.3390/jcm13206244
    By:
    • Kominami, Aoi;
    • Tomita, Shuhei;
    • Kato, Aki;
    • Ono, Koichi;
    • Takeuchi, Masaru;
    • Imazeki, Masaya;
    • Terasaki, Hiroto;
    • Yamamoto, Yuki;
    • Jujo, Tatsuya;
    • Wakuta, Makiko;
    • Matsubara, Hisashi;
    • Mitamura, Yoshinori;
    • Kondo, Mineo;
    • Kimura, Kazuhiro;
    • Takagi, Hitoshi;
    • Gomi, Fumi;
    • Sakamoto, Taiji;
    • Yasukawa, Tsutomu
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50